Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Impaired blood-brain/spinal cord barrier in ALS patients.

Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, Sallot S, Saporta S, Borlongan CV, Sanberg PR.

Brain Res. 2012 Aug 21;1469:114-28. Epub 2012 Jun 27.

PMID:
22750125
2.

Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.

Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR.

Brain Res. 2007 Jul 9;1157:126-37. Epub 2007 Apr 24.

PMID:
17512910
3.

Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.

Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV.

Acta Neuropathol. 2013 Jan;125(1):111-20. doi: 10.1007/s00401-012-1039-8. Epub 2012 Sep 1.

4.

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS.

Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR.

PLoS One. 2007 Nov 21;2(11):e1205.

5.

Blood-CNS Barrier Impairment in ALS patients versus an animal model.

Garbuzova-Davis S, Sanberg PR.

Front Cell Neurosci. 2014 Feb 3;8:21. doi: 10.3389/fncel.2014.00021. eCollection 2014. Review.

6.

Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis.

Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, Ikeda Y, Matsuura T, Abe K.

J Neurosci Res. 2011 May;89(5):718-28. doi: 10.1002/jnr.22594. Epub 2011 Feb 17.

PMID:
21337372
7.

A possible haemodynamic mechanism for amyotrophic lateral sclerosis.

Arhart RW.

Med Hypotheses. 2010 Oct;75(4):341-6. doi: 10.1016/j.mehy.2010.03.017. Epub 2010 Apr 18.

PMID:
20400230
8.

Neurovascular aspects of amyotrophic lateral sclerosis.

Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR, Voltarelli JC, Garbuzova-Davis S.

Int Rev Neurobiol. 2012;102:91-106. doi: 10.1016/B978-0-12-386986-9.00004-1. Review.

PMID:
22748827
9.

Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat.

Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, Pochet R.

Brain Res. 2009 Dec 8;1301:152-62. doi: 10.1016/j.brainres.2009.09.018. Epub 2009 Sep 11.

PMID:
19748495
10.

Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Garbuzova-Davis S, Woods RL 3rd, Louis MK, Zesiewicz TA, Kuzmin-Nichols N, Sullivan KL, Miller AM, Hernandez-Ontiveros DG, Sanberg PR.

PLoS One. 2010 May 12;5(5):e10614. doi: 10.1371/journal.pone.0010614.

11.

Amyotrophic lateral sclerosis: a neurovascular disease.

Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, Sanberg PR.

Brain Res. 2011 Jun 29;1398:113-25. doi: 10.1016/j.brainres.2011.04.049. Epub 2011 May 12. Review.

PMID:
21632035
12.

The blood-spinal cord barrier: morphology and clinical implications.

Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M.

Ann Neurol. 2011 Aug;70(2):194-206. doi: 10.1002/ana.22421. Epub 2011 Jun 14. Review.

PMID:
21674586
13.

Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis.

Sasaki S.

Neuropathology. 2015 Dec;35(6):518-28. doi: 10.1111/neup.12221. Epub 2015 Aug 4.

PMID:
26242689
14.

PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients.

Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, Goodman JC, Engelhardt JI, Siklós L, Appel SH.

J Neuropathol Exp Neurol. 2003 Jan;62(1):88-103.

15.

Survival motor neuron (SMN) protein in the spinal anterior horn cells of patients with sporadic amyotrophic lateral sclerosis.

Piao Y, Hashimoto T, Takahama S, Kakita A, Komori T, Morita T, Takahashi H, Mizutani T, Oyanagi K.

Brain Res. 2011 Feb 4;1372:152-9. doi: 10.1016/j.brainres.2010.11.070. Epub 2010 Nov 28.

PMID:
21122798
16.

Increased expression of connective tissue growth factor in amyotrophic lateral sclerosis human spinal cord.

Spliet WG, Aronica E, Ramkema M, Aten J, Troost D.

Acta Neuropathol. 2003 Nov;106(5):449-57. Epub 2003 Aug 12.

PMID:
12915949
17.

Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability.

Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV.

J Cereb Blood Flow Metab. 2012 Oct;32(10):1841-52. doi: 10.1038/jcbfm.2012.113. Epub 2012 Aug 1.

18.

Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.

Calingasan NY, Chen J, Kiaei M, Beal MF.

Neurobiol Dis. 2005 Jun-Jul;19(1-2):340-7.

PMID:
15837590
19.

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.

Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, Chiappelli F, van Kooten C, Vinters HV.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):213-9.

PMID:
15799549
20.

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S.

BMC Genomics. 2007 Jan 23;8:26.

Items per page

Supplemental Content

Write to the Help Desk